FIELD: biotechnology.
SUBSTANCE: invention relates to a method for increasing the content of Rh 2 ginsenoside and one or more ginsenosides selected from the group consisting of Rg3, Rk1, Rg5, Rk2, Rh3 and PPD, in cambial meristematic cells (CMCs) of the genus Panax that includes heat treatment of cultured cambial meristematic cells (CMCs) of the genus Panax at a temperature of 85 °C to 160 °C, cambial meristematic cells (CMCs) of the genus Panax, in which the content of ginsenoside Rh2 and one or more ginsenosides selected from the group consisting of Rg3, Rk1, Rg5, Rk2, Rh3 and PPD, increased in comparison with their content before heat treatment by the method of 1, an extract of ginseng in which the content of ginsenoside Rh2 and one or more ginsenosides selected from the group consisting of Rg3, Rk1, Rg5, Rk2, Rh3 and PPD, increased in comparison with their content before heat treatment by the method of 2, the use of cambial meristematic cells (CMCs) of the genus Panax according to 18 in the manufacture of a medicament to improve blood circulation.
EFFECT: invention makes it possible to increase the content of ginsenoside Rh2 and one or more ginsenosides selected from the group consisting of Rg3, Rk1, Rg5, Rk2, Rh3 and PPD, in cambial meristematic cells (CMCs) of the genus Panax.
20 cl, 9 dwg, 12 tbl, 4 ex
Title |
Year |
Author |
Number |
USING TREATED GINSENG EXTRACT AND SAPONINS ISOLATED FROM ITS |
2003 |
- Kim Dong-Khjun
- Rju Jong-Khoon
- Bae Ehun-Akh
- Khan Mjung-Joo
- Choo Min-Kjung
- Park Ehun-Kjung
|
RU2294208C2 |
METHOD FOR OBTAINING CULTIVATED ROOT OF RED GINSENG |
2012 |
|
RU2623245C2 |
ANTI-AGING OR ANTIOXIDANT COMPOSITION CONTAINING HERBAL STEM CELL LINE PREPARED OF CAMBIUM Panax ginseng, INCLUDING WILD GINSENG AND GINSENG AS ACTIVE INGREDIENT |
2009 |
- Dzang Mi Ok
- Lim Min Chun
- Okh Il' Sok
- Li Deh Khi
- Li Yn Kuong
- Dzin Jung Vu
|
RU2500386C2 |
COMPOSITION FOR PREVENTING OR TREATING MALIGNANT NEW GROWTH CONTAINING ACTIVE INGREDIENT PRESENTED BY HERBAL STEM CELL LINE RECOVERED FROM CAMBIUM OF PANAX GINSENG, INCLUDING WILD GINSENG OR GINSENG |
2009 |
|
RU2520625C2 |
RECOMBINANT PLANT CELLS, METHOD FOR THEIR PRODUCTION AND METHOD FOR OBTAINING OF TARGET PROTEIN THROUGH THEIR USE |
2014 |
- Chin Yun U
- Li Yn Ken
- Chan Mi Ok
- Pak Puna
- Li Soo Nan
- Yan Pu Lim
- Kim Il Sok
- O Il Sok
|
RU2636462C2 |
COMPOSITIONS OF GINSENOSIDE RG3 AND GINSENOSIDE RG5 AND THEIR PHARMACEUTICAL USES, INCLUDING ANTITUMOR EFFECTS |
2021 |
- Wang, Shuo
- Fu, Li
- Liu, Yang
- Lu, Mingming
- Lin, Rongxin
- Fu, Wenfei
- Feng, Xue
|
RU2812611C1 |
APPLICATION OF EXTRACTS OF GINSENG, GYNSENOSIDES AND DERIVATIVES OF GINSENOSIDE FOR THE PREPARATION OF MEDICAL PRODUCTS OR REMEDIES FOR THE TREATMENT OF DISORDERS CAUSED BY CMV |
2016 |
- Fu, Li
- Wang, Kaiqian
- Hui, Min
- Li, Fan
- Fan, Hongyu
- Wang, Shuo
|
RU2679903C1 |
PLANT STEM CELL LINE DERIVED FROM CAMBIUM OF HERBACEOUS PLANT WITH STORAGE ROOT AND METHOD FOR ISOLATION THEREOF |
2008 |
- Dzang Mi Ok
- Li Yn Kuong
- Dzin Jung Vu
|
RU2467067C2 |
STRAIN OF CULTURED PLANT CELLS PANAX GINSENG C A MEY - A PRODUCER OF GINSENOSIDES |
1992 |
- Zhuravlev Ju.N.
- Bulgakov V.P.
- Kozyrenko M.M.
- Ozhigova I.T.
- Eljakov G.B.
- Artjukov A.A.
- Uvarova N.I.
- Makhan'Kov V.V.
|
RU2038378C1 |
METHOD OF PRODUCING TREATED GINSENG WITH INCREASED AMOUNT OF GINSENOSIDE RG5 |
2006 |
- Chang Ju. Sap
- Choj Dzhin Khva
|
RU2358749C1 |